FranΓ§aisπ See the interactive version (live chart) β
For Allstate, we replayed every analyst price target of the past 12 months and measured the real outcome: 46% were profitable, average return +13% (252 calls). At 3 months: +3% average return (42% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Citigroup | 27 | 33% | +10% |
| Barclays | 25 | 24% | +3% |
| Raymond James | 25 | 52% | +14% |
| Keefe, Bruyette & Woods | 23 | 56% | +17% |
| Piper Sandler | 19 | 68% | +23% |
Is Allstate overvalued, and is it a good time to buy Allstate right now? If you're wondering, here's a recap to make up your own mind: Allstate's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Allstate | Sector median (Financials) |
|---|---|---|
| P/E | 5.2 | 14.0 |
| Forward P/E | 9.4 | 11.1 |
| Net margin | 19% | 24% |
π Allstate trades below its sector median (5.2 vs 14.0) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Allstate pays about $4.16/share/yr β 1.71% yield. what is this?
The analyst consensus on Allstate (ALL) is "Hold" (23 bullish, 6 bearish calls over 12 months). This is not advice: historically, 46% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $263 (+2% vs $258), ranging from $226 to $300 (14 analysts).
Over 1 year, 46% of analyst targets on Allstate were profitable, for an average return of +13% (across 252 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $263 within 12 months, i.e. +2% vs the current price. The most bullish targets $300, the most cautious $226.
Note: analyst targets are 12-month (median $263, +2%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (46%), and the stock's past trajectory.
Its P/E is 5.2, forward P/E 9.4. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Allstate β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.